To integrate into the global and regional economy, Vietnam's pharmaceutical industry has a plan to modernize the medicine production industry in order to improve product quality to raise competitiveness on the market. Under this policy, Danapha has taken steps to make in-depth investment to build soft capsules production workshop of GMP-WHO standard with the modern techniques of the pharmaceutical industry worldwide.

 

After the completion of construction of the workshop, Danapha has installed soft capsules production lines with a capacity of 200,000 capsules per day last July. This investment will significantly improve the current specifications of herbal medicines line - to help reduce the number of capsule per dosage and increase competitive advantage of the product. It is also the beginning of the development step of new herbal medicines, herbal chemical medicines and functional foods, contributing to the diversification of product portfolio of Danapha.

 

 

This is expected to bring stronger growth of OTC products, thereby boost sales, generate profits and create stableand solid growth for the company in the near future.